Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NasalCEASE and BleedCEASE

K-Number: K183622 · 2019-12-02

ApplicantLes Laboratoires Brothier S.A.
Decision Date2019-12-02
Product CodeQSY
DecisionSubstantially Equivalent

Device Summary

NasalCEASE and BleedCEASE is a medical device manufactured by Les Laboratoires Brothier S.A.. It received FDA 510(k) clearance on 2019-12-02 under approval number K183622. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NasalCEASE and BleedCEASE?

NasalCEASE and BleedCEASE is a medical device that received FDA 510(k) clearance on 2019-12-02. It is manufactured by Les Laboratoires Brothier S.A.. The 510(k) number is K183622.

When was NasalCEASE and BleedCEASE approved by the FDA?

NasalCEASE and BleedCEASE received FDA 510(k) clearance on 2019-12-02, under approval number K183622.

What company makes NasalCEASE and BleedCEASE?

NasalCEASE and BleedCEASE is manufactured by Les Laboratoires Brothier S.A..

What is the FDA product code for NasalCEASE and BleedCEASE?

The FDA product code for NasalCEASE and BleedCEASE is QSY.

Related Devices (Code: QSY)

K161013InnoSEAL Hemostatic PadInnotherapy, Inc. K160679WoundClot9Core Scientific Creation , Ltd. K160130BloodSTOP iX Battle MatrixLifescience Plus, Inc. K160578Nustat XRBeeken Biomedical, LLC K153582Prometheus ChitoGauze XR PROHem Con Medical Technologies, Inc. K161274Bondiloxs Topical Hemostatic GranulesMedtrade Products , Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑